COMPLEMENT COMPONENT C4 - ANVISA Registration 10287411470
Access comprehensive regulatory information for COMPLEMENT COMPONENT C4 in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10287411470 and manufactured by ROCHE DIAGNOSTICS GMBH. The registration is held by ROCHE DIAGNÓSTICA BRASIL LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including THE BINDING SITE GROUP LTD, BIOSYSTEMS S.A., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
10287411470
25351625899201937
30280358000186
Company Information
Dates and Status
Jan 27, 2020
VIGENTE
09/18/2025 19:00:01
COMPLEMENTO DE COMPONENTE C4
Família C4
KATAL BIOTECNOLOGICA INDÚSTRIA E COMÉRCIO LTDA
10377390288
Feb 17, 2025
COMPLEMENTO DE COMPONENTE C4
FAMÍLIA PROTEÍNA DO COMPLEMENTO C4 (Reagente A)
BIOSYSTEMS S.A.
80367750138
Sep 01, 2022
COMPLEMENTO DE COMPONENTE C4
Complement C4
THERMO FISHER SCIENTIFIC OY
80254180446
Jul 14, 2022
COMPLEMENTO DE COMPONENTE C4
Complemento C4
VYTTRA DIAGNOSTICOS S.A.
81692610208
Oct 29, 2020
COMPLEMENTO DE COMPONENTE C4
Alinity c Complement C4 Reagent Kit
ABBOTT IRELAND DIAGNOSTICS DIVISION
80146502193
Mar 18, 2019

